Relapsed Again? What Joliet Patients Do Differently the Second Time

You did the 28-day program, and then the Intensive Outpatient Program (IOP). You attended the meetings. And yet, here you are again: three months in, and the plan didn’t hold. That moment, where the effort and the outcome don’t match, is one of the most disorienting experiences in relapse recovery in Joliet.

According to the National Institutes of Health (NIH), relapse rates for substance use disorders run between 40% and 60%, comparable to relapse rates for other chronic medical conditions like hypertension and asthma. This number shows how common relapse is, and that it’s important to remember that continued use or a return to use is a normal, expected part of a chronic illness.

Whether you are considering returning, or simply researching treatment options, this article provides you with an honest, practical roadmap to life after relapsing. Find out what most programs get wrong the first time, what the evidence says about staying in treatment longer, and what non-punitive outpatient care in Joliet looks like in practice.

What Is Relapse Recovery in Joliet?

Clinicians prefer the terms “return to use” or “continued use,” because they reflect what the science actually says. Returning to opioids is a predictable feature of a chronic illness and a signal to adjust treatment. Both framings describe the same experience, rebuilding after a setback.

Rates of returning to use for people in substance use disorder treatment are comparable to those for other long-term medical conditions, which means a return to use signals that your treatment plan needs adjusting. That reframe changes everything about how your second attempt at treatment begins. 

Why Is Return to Use in Joliet the Rule, Not the Exception?

A return to use in Joliet may feel isolating, but that’s largely because most programs don’t discuss it openly. The reality is far more common than you might realize. SAMHSA’s 2024 National Survey on Drug Use and Health shows that nearly 50 million Americans, about 16.8% of people aged 12 and older, met the criteria for substance use disorder in the past year.

Among people who have tried treatment more than once, a return to use is extremely common, and expected as part of a chronic, relapsing illness. It is evidence that this illness, like any other chronic condition, requires ongoing care rather than a single course of treatment.

Ups and downs are a natural part of recovery. When you treat a return to use as data about what your treatment plan needs next, the path forward becomes much clearer. The next attempt begins with a different foundation when you understand relapse and have the right support.

What to Do After a Relapse in Joliet: The First 24 Hours

Your tolerance falls quickly after any period of reduced use, which means a previously familiar amount can now cause a life-threatening overdose. A calm, concrete plan for the next 24 hours matters more than any conversation about what comes next. You should remember to stay safe, reach out to those who care, and have your medication in reach.

Keep naloxone accessible and make sure at least one other person in your household knows how to use it. The Centers for Disease Control and Prevention note that naloxone can potentially save a life. In Illinois, pharmacists can dispense naloxone without a prescription. If you witness an overdose, give naloxone right away, call 911, and stay with the person until help arrives. 

Whom Should You Reach Out To?

Call your medical provider, your counselor, or a trusted family member. An honest conversation gives your care team the specific information they need to adjust the plan. Knowing what to do after a return to use starts with one step: reaching out to your care team as early as possible, which is consistently associated with better outcomes. 

If you are on Methadone or Suboxone® (buprenorphine-naloxone), we advise not stopping without medical guidance. Short-term withdrawal management alone carries extremely high recurrence and overdose risk, and Medications for Opioid Use Disorder (MOUD) protective benefits are greatest when they are part of a long-term plan. Your medical provider adjusts the dose or the plan.

Important: Combining Suboxone® (buprenorphine-naloxone) with benzodiazepines, alcohol, gabapentinoids, or other sedating medications significantly increases the risk of respiratory depression and overdose. Tell your medical provider about all medications you take. You won’t be denied care, but your treatment plan may need adjustment. All patients starting Suboxone® should have naloxone available at home. Stopping buprenorphine-naloxone is associated with increased risk of return to use and overdose. Evidence shows relapse risk decreases progressively with longer treatment duration; outcomes improve significantly beyond 12 to 15 months. Many patients benefit from continuing treatment indefinitely. 

What Joliet Patients Do Differently in Relapse Recovery 

Patients who found durable recovery got more specific the second time, and the times after, about what their treatment was trying to accomplish and how long they committed to staying.  

In a study of patients who experienced a non-fatal opioid overdose, researchers found that with each additional month on buprenorphine, patients experienced a 4.7% reduction in the odds of a subsequent non-fatal overdose, a 5.3% reduction in all-cause emergency department visits, and a 3.9% reduction in hospitalization. Nine months emerged as a critical retention threshold for reducing overdose risk versus shorter treatment.

Longer retention comes from giving a chronic illness the same ongoing attention you would give any other long-term condition. The intensive outpatient program is one structure that helps patients maintain that engagement.

A setback is a starting point for the next adjustment. When the care team learns the circumstances that preceded the return, they can adjust your medication doses or your support structure. Drug and alcohol addiction treatment needs to be adjusted to your goals.

The Joliet-Specific Options When You’re Ready to Come Back

Returning to treatment for relapse recovery in Joliet means coming back with more insight and support than you had the first time. That makes you a patient with a clearer picture of what works for you, and patients who understand their own patterns tend to get better-matched care. The Joliet clinic offers three primary pathways, and your care team helps determine which fits where you are now.

Is Methadone Available at the Symetria Recovery Joliet Clinic?

The clinic dispenses Methadone on-site, and most patients receive a same-day assessment and, possibly, a same-day first dose when they arrive. Unlike buprenorphine-naloxone, Methadone requires no waiting period for withdrawal symptoms to begin. Learn more about how Methadone works as a lifeline for people managing opioid use disorder.

Is Suboxone® Available for Outpatient Care?

The clinic offers Suboxone® as an office-based outpatient option. Medication initiation timing depends on your withdrawal symptoms and the substance you’ve been using. Your medical provider will determine the safest time to begin medication based on your withdrawal symptoms and review all appropriate Medications for Opioid Use Disorder options available through the Joliet clinic.

How Is Non-Punitive Addiction Treatment in Joliet Different When Use Returns?

Some outpatient programs discharge patients who continue to use or require restarting from intake. The Symetria Method® takes a different approach, and those differences are most relevant to patients returning after a return to use. Non-punitive addiction treatment in Joliet means the policy and the care model are aligned.

Your medical provider adjusts the dose or plan rather than ending care, treating the return to use as useful information about what your treatment plan needs next. 

For relapse recovery in Joliet, continuity matters as much as any other point in the journey. The care team already knows your history, triggers, and goals. The Joliet clinic is currently the only Symetria location in Will and Kendall counties, so your care team builds a genuine relationship with you.

Frequently Asked Questions

If you’re weighing a return to treatment, a few questions tend to come up first. Here are honest answers to the ones we hear most from Joliet patients and their families. 

What does relapse recovery in Joliet look like the second time around? 

The second time, you return with insight you didn’t have before. At the Symetria Joliet clinic, your care team uses what led to the return to use to adjust your medication and support, so the plan fits where you are now. 

Why do people return to use after completing treatment? 

Substance use disorder is a chronic, relapsing illness, so a return to use is common and expected, much like flare-ups in asthma or high blood pressure. Stress, life changes, and untreated mental health conditions are frequent triggers, and each one points to something your treatment plan can address. 

What should I do in the first 24 hours after a relapse in Joliet? 

Stay safe first: keep naloxone within reach, make sure someone nearby knows how to use it, and don’t stop Methadone or Suboxone® on your own. Then call your medical provider or counselor as early as you can, because reaching out quickly is consistently linked to better outcomes. 

Does returning to use mean my treatment failed? 

No, a return to use is a signal to adjust your treatment, the same way a change in blood pressure signals a change in care. It gives your team the information they need to strengthen your plan. 

Take What You Know into Your Second Attempt

A return to use is a turning point in recovery: the moment treatment adjusts and recovery becomes more durable. The patients who find lasting stability the second time are the same people, now with a more specific plan, a longer runway, and a care team that supports them through the biology of their illness. 

Ready to come back to relapse recovery in Joliet? Our team of medical providers, counselors, and care coordinators at the Symetria Recovery Joliet clinic on Hammes Avenue is ready to meet you. 

Fill out our form or call 866-955-2481 to schedule a same-day or next-day assessment, and get back to recovery.

Suboxone® is a registered trademark of Indivior UK Limited. The Symetria Method® is a registered trademark of Symetria Recovery. Symetria Recovery is not affiliated with or endorsed by Indivior. Buprenorphine/naloxone may be dispensed as a generic equivalent.

This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about your care, changing your medication, or stopping any prescribed treatment. If you are experiencing a medical emergency or overdose, call 911 immediately. Individual results vary, and nothing in this article guarantees a specific treatment outcome.